LexDanaLexDanabeta
Inventor

Masashi Kurimoto

Inventor
Okayama, JP

Overview

66→
Patents
1977–2014
Patent span
Human necessities
Primary field (CPC A)

Patents· 66 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
C07KPeptides29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C12NMicroorganisms or enzymes10%
A61QSpecific use of cosmetics or similar toiletry preparations4%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for1%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
Y02ATechnologies for adaptation to climate change1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
8,778,882'Agent for strengthening calcium containing tissue and use thereof'20147,758,853'IFN-γ production inducing protein (IGIF, IL-18)'20107,732,425'Pharmaceutical composition for ophthalmic use'20107,666,403'Mutant interferon α protein and use thereof'20107,405,048'Method for detecting a polypeptide which induces interferon-γ production'20087,355,014'Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use'20087,230,079'Antiallergic agent'20077,189,389'Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes'20077,141,393'Interleukin-18-receptor proteins'20067,135,458'Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use'20067,037,685'DNA encoding loypeptides having interferon-γ inducing activity'20066,896,880'Method for treating a disease associated with excessive osteoclast formation'20056,790,442'Genomic DNA encoding a polypeptide capable of inducing the production of interferon- '20046,773,701'Expression enhancer for protein synthesis inhibitory genes'20046,713,618'DNA which encodes trehalase and uses thereof'20046,600,022'Monoclonal antibody for human IL-18 receptor'20036,559,298'Polypeptides that bind interleukin-18 (IL-18)'20036,555,526'Pharmaceutical composition for ophthalmic use'20036,537,547'Polypeptides having L-asparaginase activity'20036,524,625'Physiologically active extract obtained from indigo plant polygonum tinctorium'20036,509,449'Monoclonal antibody specific to polypeptide which induces interferon-G production'20036,476,197'Polypeptides having interferon- inducing activity'20026,440,446'Agent for anti-osteoporosis'20026,441,138'Protein which induces interferon- production by immunocompetent cell'20026,436,396'Polypeptides having L-asparaginase activity'20026,403,079'Process for producing a pharmaceutical composition containing a protein which induces interferon- production by an immunocompetent cell'20026,368,845'Polypeptides having L-asparaginase activity'20026,299,871'Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases'20016,277,598'DNA molecule encoding interferon-gamma (IFN-.lambda.) inducing factor (IGIF, IL-18) and DNA fragment thereof'20016,274,709'Interferon-gamma (IFN-.gamma.) inducing factor (IGIF, IL-18) and peptide fragment thereof'20016,274,367'DNA coding for mammalian L-asparaginase'20016,268,486'Process for purifying a polypeptide'20016,242,255'Protein which induces interferon-gamma production by immunocompetent cell'20016,214,584'Human Interferon-.gamma.inducing factor'20016,207,641'Pharmaceutical composition containing IFN-.gamma. inducing polypeptide or factor for treating and/or preventing IFN-.gamma. susceptive diseases'20016,197,297'Monoclonal antibody specific to polypeptide which induces interferon-gamma production'20016,140,101'Polypeptides having L-asparaginase activity'20006,087,116'Interleukin-18 (IL-18) receptor polypeptides and their uses'20006,087,151'DNA coding for mammalian L-asparaginase'20006,060,283'Genomic DNA encoding human interleukin-18 (IL-18, interferon-.gamma. inducing factor)'20005,914,253'Recombinant production of murine interferon--.gamma. (IFN-.gamma.) inducing factor (IGIF, IL-18)'19995,912,324'Interferon-gamma (IFN-.gamma.) inducing factor (IGIF, IL-18) purified from murine liver'19995,910,303'Agent for promoting the platelet and the leukocyte productions'19995,891,663'Process for preparing polypeptide'19995,879,942'Processing enzyme for polypeptide'19995,874,401'Cedar pollen protein and use thereof in treating, preventing, and diagnosing pollenosis'19995,830,914'Apoptosis-controlling agent'19985,827,691'Process for preparing a protein which inhibits metastasis of cancer'19985,710,179'Antitumor agent'19985,672,692'Purification of human myelomonocyte interferon gamma with an immobilized antibody'19975,631,221'Pollenosis-inducing polypeptide, process for preparing the same, and uses thereof'19975,554,515'Preparation of a monoclonal antibody specific to human myelomonocyte interferon-gamma'19965,518,899'Preparation of human myelomonocyte interferon-gamma'19965,498,697'Protein possessing metastasis-inhibitory activity'19965,362,490'Human myelomonocyte interferon-gamma, and process for preparation and use thereof'19945,331,091'Melanin formation-inhibitory protein, and its preparation and uses'19945,262,153'Skin-whitening agent'19935,126,148'Process to prepare metastasis-inhibitory factor'19925,077,059'Process for preparing melanogenic inhibitor, and pigmentation-lightening agent containing the same'19915,030,564'Monoclonal antibody specific to the lymphokine LK 2 and its method of production'19915,019,385'Novel lymphopine LK 2 and pharmaceutic compositions containing same'19915,002,878'Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses'19915,003,048'Method for the purification of lymphokine LK 2'19914,994,556'Novel lymphokine and its production and uses'19914,758,549'Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses'19884,016,038'Process for preparing maltoses from starches'1977

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1977–2014Patents assigned to HAYASHIBARA CO (2)· patent assignee history
1977–2014Based in Okayama, JP· patent location history
1988–2010Patents assigned to HAYASHIBARA BIOCHEM LAB (60)· patent assignee history
1991–1993Patents assigned to SANSHO SEIYAKU KK (2)· patent assignee history
2007–2014Patents assigned to KURIMOTO MASASHI (2)· patent assignee history
2007Patents assigned to ARAI NORIE (1)· patent assignee history
2010Based in Okayamai, JP· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HAYASHIBARA BIOCHEM LAB601988–2010
HAYASHIBARA CO21977–2014
KURIMOTO MASASHIself22007–2014
SANSHO SEIYAKU KK21991–1993
ARAI NORIE12007
Locations
LocationPatentsSpan
Okayama, JP651977–2014
Okayamai, JP12010